Medication info

Ariranitidine Hydrochloride Tablet 150 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Arise Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906410 · Approved 2019.09.11

This product's status changed to Expired on 2024.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
1. Adults As ranitidine, 150mg is administered orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers As this drug, 150mg is administered orally twice daily, or 300mg is administered once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300mg twice daily, in the morning and at bedtime. The dosage and administration are the same when this drug is used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, 150mg is administered once daily at bedtime as maintenance therapy. 2) Reflux esophagitis As this drug, 150mg is administered twice daily for 8 weeks, or 300mg is administered once daily before bedtime. The dose may be increased to 150mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome As this drug, treatment is initiated at a dose of 150mg 3 times daily, which may be increased as needed. In severe cases, up to 6g daily may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of this drug at 150mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) As this drug, 150mg is administered 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis As this drug, 150mg is administered once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and a creatinine clearance of 50mL/min or less, 150mg is administered once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted appropriately according to age and symptoms.
Child dose
For ages 8 ~ 18 years, 150mg per dose (2mg per kg of body weight) may be administered up to twice daily.

Ingredients

Manufacturer
Arise Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal redness
  • gastric mucosal swelling
  • acute gastritis
  • exacerbation of chronic gastritis
View approved original text

This medication is effective for various gastrointestinal diseases, including gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is particularly useful for the prevention and treatment of ulcers caused by surgical procedures or NSAID use. Additionally, it helps improve gastric mucosal lesions such as exacerbation of acute and chronic gastritis and upper gastrointestinal bleeding. This medication alleviates inflammation, bleeding, redness, and swelling in the gastric mucosa and is used to enhance gastrointestinal health.

How to take

Adult dose

1. Adults As ranitidine, 150mg is administered orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers As this drug, 150mg is administered orally twice daily, or 300mg is administered once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300mg twice daily, in the morning and at bedtime. The dosage and administration are the same when this drug is used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, 150mg is administered once daily at bedtime as maintenance therapy. 2) Reflux esophagitis As this drug, 150mg is administered twice daily for 8 weeks, or 300mg is administered once daily before bedtime. The dose may be increased to 150mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome As this drug, treatment is initiated at a dose of 150mg 3 times daily, which may be increased as needed. In severe cases, up to 6g daily may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration of this drug at 150mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) As this drug, 150mg is administered 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis As this drug, 150mg is administered once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and a creatinine clearance of 50mL/min or less, 150mg is administered once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted appropriately according to age and symptoms.

Child dose

For ages 8 ~ 18 years, 150mg per dose (2mg per kg of body weight) may be administered up to twice daily.

Precautions

This medication should not be used in patients with a known allergy to any of its components or with a history of acute porphyria. Additionally, patients with genetic issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication. Patients with poor kidney function may have delayed elimination of this medication, therefore the dosage should be reduced or the dosing interval increased, and cautious use is necessary for patients with impaired liver function. Patients with a history of drug allergy reactions, elderly patients, and those taking non-steroidal anti-inflammatory drugs (NSAIDs) should use this medication with caution. This medication may conceal symptoms of gastric cancer, so gastric ulcer patients or middle-aged patients with newly developed indigestion symptoms should verify whether it is cancer before use. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should also receive eradication therapy. Rarely, this medication may cause severe allergic reactions or abnormalities in blood, liver dysfunction, heart issues, gastrointestinal symptoms, neurological symptoms, myalgia, or skin reactions; if any unusual symptoms occur, stop taking it immediately and consult healthcare professionals. Regular blood tests and liver and kidney function tests should be conducted during treatment to monitor the condition. Elderly patients, chronic lung disease patients, diabetics, and patients with weakened immunity may be at an increased risk of pneumonia when taking this medication, so caution is necessary. Avoid driving or operating dangerous machinery if dizziness or drowsiness occurs after taking this medication. This medication can affect the absorption or metabolism of other drugs, so inform healthcare professionals when taking other medications and monitor closely. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and breastfeeding women should only take it when necessary. The safety for children has not been adequately established, so caution is needed in usage. No serious issues have been reported from overdose, but appropriate treatment such as vomiting or gastric lavage may be necessary. This medication should be kept out of reach of children, and transferring it to other containers should be avoided.

Side effects

Anaphylactic shock, urticaria, angioedema, rash, fever, bronchospasm, hypotension, chest pain, agranulocytosis, elevated serum creatinine level, leukopenia, thrombocytopenia, bone marrow suppression, aplastic anemia, hypoplastic anemia, pure red cell aplasia, eosinophilia, general fatigue, weakness, subcutaneous and mucosal bleeding, fever, transient and reversible liver dysfunction, jaundice, hepatitis, bradycardia, atrioventricular block, tachycardia, vasculitis, constipation, nausea, vomiting, abdominal distension, abdominal pain, loss of appetite, diarrhea, acute pancreatitis, dizziness, drowsiness, convulsions, headache, heaviness in the head, insomnia, excitement, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorders, consciousness disorders, hepatic myoclonus, gynecomastia, galactorrhea, erectile dysfunction, decreased libido, arthralgia, myalgia, rhabdomyolysis, skin rash, erythema multiforme, alopecia, glossitis, pruritus, mucocutaneous syndrome, toxic epidermal necrolysis, acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that protects it from light. Also, it is important to maintain the medication's efficacy by storing it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.